Pille A, Meillat H, Braticevic C, Lelong B, Rousseau F, Cecile M, Tassy L
Service d'Oncologie médicale, Institut Paoli-Calmettes, 232 bd Sainte Marguerite, Marseille, 13009, France.
Service de chirurgie oncologique digestive, Institut Paoli-Calmettes, Marseille, France.
Aging Clin Exp Res. 2024 Aug 9;36(1):163. doi: 10.1007/s40520-024-02752-4.
In Europe, CRC is the second most common cause of cancer death, and surgery remains the mainstay curative treatment. Age and frailty are associated with an increased risk of postoperative morbidity and 1-year mortality. Chronological age is not sufficient to assess the risk of postoperative complications. The CGA has been developed to better identify frail patients. Geriatric co-management have been developed to optimize the post-operative outcomes. We analyzed the real-life of geriatric co-management within an ERAS program on surgical outcomes at 90 days and oncologic outcomes at 1 year in patients aged 70 years or older after surgery for CRC. This was a retrospective study based on a prospective cohort. Fifty-one patients with a G8 score ≤ 14 were referred to geriatricians for preoperative CGA (Frail Group). They were compared with 151 patients with a G8 score ≥ 15 (Robust Group). In the Frail Group, patients were significantly older with more comorbidities than the patients in the Robust Group. Oncologic characteristics, treatments and global post-operative outcomes were comparable between the two groups. One year after surgery mortality and recurrence rates were similar between the two groups. Our study suggests that geriatric co-management is feasible and contributes to the reduction of postoperative morbimortality. Moreover, performing the CGA after G8 score screening and completion of geriatric interventions resulted in similar 90-day postoperative outcomes, in frail patients than in robust patients. Our results confirmed the benefit of geriatric co-management, involving G8 screening, CGA, and ERAS, for frail older patients undergoing surgery for CRC.
在欧洲,结直肠癌是癌症死亡的第二大常见原因,手术仍然是主要的根治性治疗方法。年龄和身体虚弱与术后发病率和1年死亡率的增加相关。实际年龄不足以评估术后并发症的风险。已开发出综合老年评估(CGA)以更好地识别身体虚弱的患者。已开展老年共同管理以优化术后结果。我们分析了在加速康复外科(ERAS)计划中对70岁及以上结直肠癌手术后患者90天手术结局和1年肿瘤学结局进行老年共同管理的实际情况。这是一项基于前瞻性队列的回顾性研究。51名G8评分≤14的患者被转介给老年病科医生进行术前综合老年评估(虚弱组)。他们与151名G8评分≥15的患者(强健组)进行比较。在虚弱组中,患者的年龄明显更大,合并症比强健组的患者更多。两组之间的肿瘤学特征、治疗方法和总体术后结局具有可比性。两组术后1年的死亡率和复发率相似。我们的研究表明,老年共同管理是可行的,有助于降低术后病死亡率。此外,在G8评分筛查和老年干预完成后进行综合老年评估,虚弱患者与强健患者的术后90天结局相似。我们的结果证实了老年共同管理(包括G8筛查、综合老年评估和加速康复外科)对接受结直肠癌手术的虚弱老年患者的益处。